Cargando…

Active HPV infection and its influence on survival in head and neck squamous-cell cancer

PURPOSE: HPV is involved in the development of some head and neck squamous-cell carcinomas (HNSCC). It was suggested that only transcriptionally active virus can induce carcinogenesis, therefore, the aim of our study was to analyze the frequency of active HPV infection, virus type, and its prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janecka-Widła, Anna, Mucha-Małecka, Anna, Majchrzyk, Kaja, Halaszka, Krzysztof, Przewoźnik, Marcin, Słonina, Dorota, Biesaga, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256081/ https://www.ncbi.nlm.nih.gov/pubmed/32372145 http://dx.doi.org/10.1007/s00432-020-03218-6

Ejemplares similares

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
por: Biesaga, Beata, et al.
Publicado: (2017)

Differences between Squamous Cell Carcinomas of the Base of the Tongue and the Tonsils in Prevalence of HPV16 Infection, Its Type, and Clinical Features
por: Biesaga, Beata, et al.
Publicado: (2023)

Low frequency of HPV positivity in breast tumors among patients from south-central Poland
por: Biesaga, Beata, et al.
Publicado: (2021)

Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx
por: Biesaga, Beata, et al.
Publicado: (2022)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment
por: Adamczyk, Agnieszka, et al.
Publicado: (2018)

Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy
por: Mucha-Małecka, Anna, et al.
Publicado: (2021)

Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer
por: Snietura, Miroslaw, et al.
Publicado: (2010)

Current trends in the etiology and diagnosis of HPV-related head and neck cancers
por: Chai, Ryan C, et al.
Publicado: (2015)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
por: Ferris, Robert L, et al.
Publicado: (2021)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

Relationship between TNF-α −1031T/C gene polymorphism, plasma level of TNF-α, and risk of cachexia in head and neck cancer patients
por: Powrózek, Tomasz, et al.
Publicado: (2018)

FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis
por: Huang, Junjie, et al.
Publicado: (2021)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies
por: Auguste, Aviane, et al.
Publicado: (2020)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
por: Brewczyński, Adam, et al.
Publicado: (2020)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland
por: Słonina, Dorota, et al.
Publicado: (2014)

Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015)

Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
por: Fan, Cui, et al.
Publicado: (2021)

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma
por: Weed, Donald T., et al.
Publicado: (2023)

Body composition analysis in head and neck squamous cell carcinoma
por: Malecka-Massalska, Teresa, et al.
Publicado: (2013)

The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Sharkey Ochoa, Imogen, et al.
Publicado: (2022)

HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
por: Zhao, Hongyu, et al.
Publicado: (2022)

Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis
por: Zhang, Siqi, et al.
Publicado: (2022)

Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zeitlin, Ross, et al.
Publicado: (2015)

HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
por: Augustin, Jeremy Gbenakpon, et al.
Publicado: (2020)

Analysis of the anatomical distribution of HPV genotypes in head and neck squamous papillomas
por: Hu, Huiying, et al.
Publicado: (2023)

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review
por: Swartz, Justin E, et al.
Publicado: (2015)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

Oral hygiene and the overall survival of head and neck cancer patients
por: Chang, Chan‐Chi, et al.
Publicado: (2019)

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients
por: Qian, Xu, et al.
Publicado: (2019)

Comparative molecular profiling of HPV‐induced squamous cell carcinomas
por: Koncar, Robert F., et al.
Publicado: (2017)

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas
por: Wong, Nathan, et al.
Publicado: (2016)

The prognostic role of C‐reactive protein in patients with head and neck squamous cell carcinoma: A meta‐analysis
por: Chen, Yanglan, et al.
Publicado: (2020)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
por: Fialová, Anna, et al.
Publicado: (2020)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_im4m65ka8baskuv8i2bdql3226